The Selux PBC Separator With Selux AST System Receives FDA 510(k) Clearance for Rapid Antibiotic Susceptibility Testing Direct From Positive Blood CultureFebruary 26, 2024
Dr. James S. Lewis II, Antibiotic Susceptibility Test Expert, Joins as Chair of Selux Diagnostics’ Clinical Advisory BoardOctober 18, 2022
Selux Diagnostics Awarded $2.8 Million Grant from NIH for Commercialization of its NGP PlatformOctober 19, 2021
Selux Diagnostics Earns FDA Breakthrough Device Designation for Next Generation ‘Phenotyping’ (NGP) Platform for Positive Blood Culture and Sterile Body Fluid SamplesSeptember 28, 2021
